Maximus Inc.
MMSBusiness Overview
source: coverage-next-full ticker: MMS step: "01" title: Business Overview — Maximus Inc. created: 2026-05-29
Step 01: Business Overview
Company Narrative
Maximus Inc. is the dominant independent provider of health and human services (HHS) program administration in the United States. Founded in 1975, the company has built a 50-year track record delivering government-mandated social programs — Medicaid, Medicare, unemployment insurance, ACA enrollment, veterans' evaluations, child support, and workforce development — on behalf of federal, state, and local agencies.
The core value proposition is straightforward: government agencies have large, complex programs with variable caseloads and staffing requirements that are difficult to manage in-house. Maximus provides the technology infrastructure, trained workforce, compliance frameworks, and operational expertise to administer these programs at scale — typically at lower cost than government direct administration.
Business Model
Maximus earns revenue through three primary contract structures:
- Cost-Plus / Time & Materials: Government reimburses Maximus's costs plus a fee. Lower margin but predictable. Common in federal contracts where scope is uncertain.
- Fixed-Price / Firm-Fixed-Price: Maximus receives a fixed payment per deliverable or per period. Higher risk but higher potential margin if operations are efficient. Incentivizes Maximus to improve processes.
- Performance-Based: Payments tied to outcomes (e.g., successful job placements in welfare-to-work programs, enrollment rates). Growing share of contracts as governments seek accountability.
The model generates highly recurring, multi-year revenue. Average contract lengths run 3–7 years with renewal options. Switching costs for governments are high — re-procurement is expensive, disruptive, and politically risky. Maximus retains the majority of its contracts upon re-compete.
Segment Overview
US Federal Services (~60% of Revenue, ~$3.2B FY2024)
The largest and fastest-growing segment following the January 2022 acquisition of Veterans Evaluation Services (VES) for approximately $1.5 billion. Key programs:
- VES (Veterans Evaluation Services): Conducts disability and pension examinations for veterans on behalf of the Department of Veterans Affairs (VA). High-volume, standardized exams across a nationwide network of clinicians. Largest single program by revenue within the federal segment.
- CMS Medicare Appeals (MAXIMUS Federal Services): Administers the Medicare appeals process — Qualified Independent Contractor (QIC) role — providing independent review of Medicare coverage and payment decisions.
- CMS Medicaid & CHIP Operations: Federal oversight and data support for state Medicaid programs.
- Other Federal: DoD, DHS, Social Security Administration, and other HHS-adjacent agencies.
US Services (~30% of Revenue, ~$1.6B FY2024)
State and local government program administration — the historical core of the business:
- Medicaid Eligibility & Enrollment: Call centers, eligibility determination, renewal processing. The Medicaid continuous enrollment unwinding (April 2023 – present) created a significant redetermination revenue tailwind as states processed 90M+ eligibility reviews.
- ACA Marketplace Enrollment Assistance: Federally-funded navigator programs and state marketplace support.
- Unemployment Insurance: Contact center and eligibility administration for state workforce agencies. COVID-era UI surge (FY2020–FY2021) was non-recurring; volumes have normalized.
- Workforce Development: Welfare-to-work, job training, employment services.
- Child Support: Locate, establish, and enforce child support orders for state agencies.
Outside the US (~10% of Revenue, ~$450M FY2024)
Operations primarily in the United Kingdom, Australia, and Canada:
- UK: Employment and welfare-to-work programs (Work Programme successors), disability assessments (PIP — Personal Independence Payment), employment support services.
- Australia: Employment services under the Australian Government's Workforce Australia program.
- Canada: Smaller-scale health and employment program administration.
Competitive Position
Maximus is the largest pure-play government HHS outsourcing company. Its positioning is distinct from:
- IT-heavy govcon firms (Leidos, SAIC, Booz Allen): Maximus is operational/BPO-first, not IT project delivery
- Diversified outsourcers (Accenture Federal, Conduent): Maximus's HHS specialization is deeper
- Healthcare administrators (Molina, Centene): Maximus administers but doesn't bear insurance risk
Key Programs (Revenue Concentration)
| Program | Agency | Approximate Revenue | Contract Type |
|---|---|---|---|
| Veterans disability exams (VES) | VA | ~$800M+ | Cost-Plus |
| Medicare appeals (QIC) | CMS | ~$300-400M | Fixed-Price |
| Medicaid eligibility (multiple states) | State HHS | ~$500M+ | Varies |
| UK employment/disability | DWP | ~$250M | Performance |
| ACA marketplace/navigator | CMS/States | ~$150M | Fixed-Price |
Growth Drivers (FY2024–FY2026)
- Medicaid redetermination: Peaked ~FY2024 but created new enrollment management relationships
- VES organic growth: VA disability claims backlog remains elevated; exam volumes growing
- Technology/AI integration: Maximus investing in AI-enhanced service delivery to improve margins
- Federal expansion: New agency relationships beyond CMS and VA
- International (selective): UK and Australia program wins
Financial Snapshot
source: coverage-next-full ticker: MMS step: "04" title: Financial Snapshot — P&L, Margins, Key Metrics created: 2026-05-29
Step 04: Financial Snapshot
Income Statement Summary (FY2020–FY2024)
| Metric | FY2020 | FY2021 | FY2022 | FY2023 | FY2024E |
|---|---|---|---|---|---|
| Revenue | $3,044M | $4,254M | $4,253M | $4,907M | $5,279M |
| YoY Growth | +4.8% | +39.7% | -0.0% | +15.4% | +7.6% |
| Gross Profit | ~$600M | ~$750M | ~$700M | ~$810M | ~$870M |
| Gross Margin | ~19.7% | ~17.6% | ~16.5% | ~16.5% | ~16.5% |
| Operating Income | ~$275M | ~$330M | ~$370M | ~$430M | ~$480M |
| Operating Margin | ~9.0% | ~7.8% | ~8.7% | ~8.8% | ~9.1% |
| Net Income | ~$190M | ~$220M | ~$240M | ~$290M | ~$330M |
| Diluted EPS | $3.01 | $3.48 | $3.84 | $4.64 | $5.42 |
| Adjusted EPS | ~$3.20 | ~$3.60 | $4.21 | $5.18 | $5.85 |
Note: FY2021 revenue surge driven by COVID-era unemployment insurance processing. FY2022 reflects VES acquisition ($1.5B, closed Jan 2022) partially offset by UI normalization. Adjusted EPS excludes amortization of acquired intangibles and certain transaction costs.
Key Margin Analysis
Gross Margin Trend
Maximus's gross margins (~16–20%) are lower than pure SaaS peers but consistent with labor-intensive BPO businesses. The VES acquisition diluted gross margins slightly (cost-plus structure generates lower gross margins than state fixed-price contracts) but improved operating leverage at the EBITDA level through scale.
Gross margin pressures:
- Labor inflation: ~70–75% of COGS is labor; wage inflation 2021–2023 was a headwind
- Contract mix: More federal cost-plus = lower gross margin
- Medicaid redetermination: Task orders at US Services improved utilization; mix tailwind during peak
Operating Margin Drivers
Operating margins (8–9%) are driven by:
- SG&A leverage: Relatively fixed corporate overhead spread over growing revenue base
- Business development (bid & proposal) costs: Expensed as incurred; can fluctuate with recompete activity
- Technology investment: Maximus has been reinvesting in automation/AI — dilutive short-term, accretive medium-term
- Amortization: VES acquisition created significant acquired intangibles; amortization ~$80–100M/year
EBITDA
| Metric | FY2022 | FY2023 | FY2024E |
|---|---|---|---|
| Operating Income | $370M | $430M | $480M |
| D&A (total) | ~$150M | ~$155M | ~$160M |
| EBITDA | ~$520M | ~$585M | ~$640M |
| EBITDA Margin | ~12.2% | ~11.9% | ~12.1% |
| Adjusted EBITDA | ~$560M | ~$635M | ~$690M |
The gap between reported and adjusted EBITDA reflects primarily acquired intangible amortization from VES.
COVID-Era Program Surge & Normalization
The revenue trajectory requires careful interpretation:
FY2021 UI surge: COVID pandemic drove an unprecedented surge in unemployment insurance claims. State UI systems were overwhelmed; Maximus rapidly scaled contact center operations. This added ~$700–900M in non-recurring UI revenue vs. baseline. As UI claims normalized FY2022–2023, US Services revenue faced a structural headwind offset by Medicaid continuous enrollment.
FY2022–2023 Medicaid continuous enrollment: The PHE (Public Health Emergency) prohibited states from disenrolling Medicaid beneficiaries. This kept Maximus's Medicaid workload elevated with limited eligibility churn. When the PHE ended April 2023, states began "unwinding" — re-verifying all 90M+ Medicaid enrollees within 12-24 months. This created substantial redetermination revenue for Maximus as states needed surge capacity.
FY2024 onward: Medicaid redetermination revenue peaks and normalizes. The underlying Medicaid business (lower volume) will settle at a new run rate. VES continues growing. The net result: revenue growth slowing from ~15% to mid-single-digits.
Valuation Context
| Metric | Current (~$75-80/share) |
|---|---|
| Market Cap | ~$4.5B |
| Enterprise Value | ~$5.7B (incl. ~$1.2B net debt) |
| EV/Revenue | ~1.1x |
| EV/EBITDA | ~8.3x (adjusted) |
| P/E (adjusted) | ~13x |
| P/E (GAAP) | ~14-15x |
| Dividend Yield | ~1.5% ($1.12/share) |
MMS trades at a discount to broader IT services peers (EV/EBITDA 10–14x) reflecting government contract risk, leverage from VES, and Medicaid normalization headwind. The discount appears excessive given revenue visibility and dividend support.
One-Time Items & Adjustments
| Item | Year | Impact | Notes |
|---|---|---|---|
| VES acquisition costs | FY2022 | -~$20M | Transaction and integration |
| Acquired intangible amortization | FY2022–ongoing | -$80-100M/yr | Primarily VES customer relationships |
| Restructuring charges | FY2022 | -~$15M | Workforce rationalization |
| Attain LLC acquisition | FY2022 | -~$5M | Smaller federal IT acquisition |
| Legal settlements | Various | Immaterial | Normal course |
Tax Rate & Interest
| Metric | FY2022 | FY2023 | FY2024E |
|---|---|---|---|
| Effective Tax Rate | ~25% | ~26% | ~26% |
| Interest Expense (gross) | ~$55M | ~$70M | ~$65M |
| Cash Interest (approx.) | ~$50M | ~$65M | ~$60M |
Interest expense elevated post-VES but declining as debt is paid down. Net debt reduction of ~$300M/year is achievable given strong FCF.
Deeper Financial Analysis
The fundamental tier adds 9 additional research dimensions for $MMS.